Experiencing shortness of breath can be scary
Selective and membrane-permeable small-molecule inhibitors of NNMT reverse high-fat-diet-induced obesity in mice and remodel adipocyte metabolism (open-access)
retatrutide, a triple compound of GIP, GLP-1 and glucagon receptor agonists
Toast and an egg A very realistic protein-first breakfast when you need something familiar, bland, and not too ambitious
All of the drugmakers face the prospect of more local competition in China, where Novo's patent on Wegovy's active ingredient semaglutide expires in 2026 and companies like CSPC Pharmaceutical Group and Hangzhou Jiuyuan Genetic Biopharmaceutical Co are developing their own versions of the drug
Results vary based on individual factors like adherence, metabolism, and lifestyle